Killer antibodies against AML
Killer antibodies against AML
Multiple myeloma highlights from EHA 2016
Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia
RNA regulation of JAK-STAT pathways in CML
An overview of MCL from EHA 2016
Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer.
MyPathway guidance of targeted therapy based on molecular profiles
Update on olaparib in ovarian cancer
Phase I study of sapacitabine and seliciclib in patients with advanced solid tumours
ASCO 2016: Plenary Session Review
Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery
Novel antibody helps patients with advanced gastric cancer live longer